Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Oct
30
2023
 FDA’s New Enforcement Policy: A Win for Remote Patient Monitoring and Remote Therapeutic Monitoring Manufacturers Foley & Lardner LLP
Oct
30
2023
 Study Finds One-Third of Chocolate Contains High Levels of Heavy Metals Keller and Heckman LLP
Oct
30
2023
 Compensation for Food Handler Certification in California Jackson Lewis P.C.
Oct
27
2023
 HRSA Issues Notice Confirming 340B Registration Requirement McDermott Will & Emery
Oct
27
2023
 New Antidumping and Countervailing Petitions on Frozen Warmwater Shrimp from Ecuador, India, Indonesia, and Vietnam ArentFox Schiff LLP
Oct
26
2023
 GT Legal Food Talk Episode 22: Supplementing Your Pet’s Lifestyle with Bill Bookout and the National Animal Supplement Council Greenberg Traurig, LLP
Oct
26
2023
 FDA Issues New Warning Regarding Compounded Ketamine Foley & Lardner LLP
Oct
26
2023
 Big Law Redefined: Episode 9 | Beware, New Beauty Brands! Greenberg Traurig, LLP
Oct
25
2023
 NanoHarmony Publishes White Paper on OECD Test Guideline Development Bergeson & Campbell, P.C.
Oct
25
2023
 Connecticut Follows in the Footsteps of Other Jurisdictions Requiring Registration of Pharmaceutical Representatives Sheppard, Mullin, Richter & Hampton LLP
Oct
25
2023
 California Bans Several FDA-Authorized Food Additives; New York May Soon Follow ArentFox Schiff LLP
Oct
25
2023
 DEA Further Extends Flexibilities for Controlled-Substance Prescribing Via Telemedicine McDermott Will & Emery
Oct
25
2023
 FDA Publishes FY 2021 Pesticide Residue Report Keller and Heckman LLP
Oct
24
2023
 Congress May Have a Vision for Psychedelic Regulation in the US Epstein Becker & Green, P.C.
Oct
24
2023
 Stocking Naloxone in the Workplace: What Employers Need to Consider Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Oct
24
2023
 Telehealth Update: DEA Extends Flexibility in Prescribing Controlled Substances via Telehealth Through 2024 Mintz
Oct
24
2023
 FDA Updates Guidance Regarding Scientific Communications to HCPs about Unapproved Uses of Approved/Cleared Medical Devices and Drugs Nelson Mullins
Oct
24
2023
 DEA Issues Second Temporary Extension of COVID-19 Telemedicine Prescribing Flexibilities, Through 2024 Epstein Becker & Green, P.C.
Oct
24
2023
 DEA Further Extends COVID-19 Telemedicine Prescribing Flexibilities through December 31, 2024 Robinson & Cole LLP
Oct
24
2023
 EPA Announces Winners of the 2023 Green Chemistry Challenge Awards Bergeson & Campbell, P.C.
Oct
24
2023
 FDA Seeks to Increase Regulatory Oversight of Laboratory Developed Tests ArentFox Schiff LLP
Oct
24
2023
 Lawsuit Alleges Panera’s Caffeinated Lemonade Caused Death Keller and Heckman LLP
Oct
24
2023
 In This Case, "Primarily" Means A Small Fraction Allen Matkins Leck Gamble Mallory & Natsis LLP
Oct
23
2023
 OCR Cybersecurity Newsletter Emphasizes Significance of HIPAA Sanction Policies Mintz
Oct
23
2023
 California Bans Four Federally Cleared Additives From Use in Food K&L Gates LLP
Oct
23
2023
 FDA Deputy Commissioner for Human Foods Expresses Commitment to Human Foods Program Framework Keller and Heckman LLP
Oct
23
2023
 Safeguarding AI Innovation in Stem Cell Therapy Foley & Lardner LLP
Oct
22
2023
 NNI Nanoinformatics Conference and U.S.-EU NanoEHS COR Workshop Will Be Held in November 2023 Bergeson & Campbell, P.C.
Displaying 1261 - 1288 of 11744
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins